Back

A simple ex vivo bladder infection model permits study of host-pathogen interactions in UTI

Koehn, R.-M.; Durand, M.; Ramirez Finn, L.; Costas, A.; Soderstrom, B.; Lacerda Mariano, L.; Ingersoll, M. A.

2024-12-23 immunology
10.1101/2024.12.23.630047 bioRxiv
Show abstract

Urinary tract infections (UTI) are one of the most common infections, worldwide. To understand mechanisms of UTI pathogenesis and find new treatments, researchers often use animal models, such as mice or rats. However, studying certain phenotypes in animals can be difficult. Additionally, using animals in research comes with significant administrative and ethical challenges. To address these challenges, we developed a simple, reproducible, and cost-effective model to study UTI using donated mouse bladder tissue that would otherwise be discarded. This model allows researchers of all experience levels to study interactions between the host and pathogen in a controlled environment. We tested uropathogenic E. coli colonization and invasion of isolated urothelial sheets from 30 minutes to 24 hours, finding that bacterial burden in our ex vivo model was comparable to in vivo UTI mouse models. To optimize reproducibility, we tested multiple variables, including technical parameters, such as incubator conditions, and biological factors, such as biological sex or prior pregnancy in the donor mouse. This method offers several advantages, including assessment of early host-pathogen interactions, immune cell uptake of bacteria, the impact of age and sex of donor animals in infection, and diverse bacterial strains, mutants, or treatments. In addition, in some countries, sharing material recovered from animals sacrificed for other reasons does not require additional ethical approval by the receiving laboratory, providing a resource for labs without access to animals and reducing administrative burden. Given the breadth of the model with respect to sex, age, mouse and bacterial strain, and the ability to test any parameter that can be included in a 96-well plate, we believe this model will be useful to UTI researchers, with potential application beyond infection or even beyond the bladder to other tissues.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.1%
35.0%
2
PLOS ONE
4510 papers in training set
Top 16%
11.1%
3
Scientific Reports
3102 papers in training set
Top 7%
9.7%
50% of probability mass above
4
Infection and Immunity
103 papers in training set
Top 0.2%
3.8%
5
mBio
750 papers in training set
Top 6%
2.5%
6
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.2%
7
Frontiers in Microbiology
375 papers in training set
Top 4%
1.9%
8
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.6%
9
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.1%
1.4%
10
Microbiology Spectrum
435 papers in training set
Top 4%
1.0%
11
Kidney360
22 papers in training set
Top 0.5%
1.0%
12
JCI Insight
241 papers in training set
Top 6%
0.9%
13
mSphere
281 papers in training set
Top 5%
0.9%
14
PLOS Biology
408 papers in training set
Top 15%
0.9%
15
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
16
eLife
5422 papers in training set
Top 54%
0.8%
17
mSystems
361 papers in training set
Top 7%
0.8%
18
Microbiome
139 papers in training set
Top 3%
0.8%
19
BMC Medical Genomics
36 papers in training set
Top 1%
0.8%
20
Diagnostics
48 papers in training set
Top 2%
0.8%
21
American Journal of Infection Control
12 papers in training set
Top 0.3%
0.8%
22
Journal of Applied Microbiology
18 papers in training set
Top 0.4%
0.8%
23
Journal of Clinical Microbiology
120 papers in training set
Top 1%
0.8%
24
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
25
JAC-Antimicrobial Resistance
13 papers in training set
Top 0.4%
0.8%
26
Biofilm
15 papers in training set
Top 0.1%
0.8%
27
PLOS Pathogens
721 papers in training set
Top 10%
0.5%
28
Frontiers in Oncology
95 papers in training set
Top 4%
0.5%